Home › Acute Myeloid Leukemia › Michigan › Detroit

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Detroit, MI

14 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Detroit (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Wayne State University/Karmanos Cancer Institute, Detroit
Henry Ford Hospital, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Henry Ford Hospital, Detroit
Henry Ford Health Saint John Hospital, Detroit

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3

Henry Ford Health System, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Henry Ford Hospital, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Wayne State University/Karmanos Cancer Institute, Detroit

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2

Children's Hospital of Michigan, Detroit

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3

Children's Hospital of Michigan, Detroit

29 Days – 21 Years · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

Wayne State University School of Medicine, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Karmanos Cancer Institute, Detroit
Henry Ford Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Nagre-recruitPhase 3

Henry Ford Cancer Institute, Detroit

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Michigan, Detroit
Henry Ford Health System, Detroit

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

Karmanos Cancer Institute, Detroit

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

Karmanos Cancer Institute, Detroit

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

HPC Offered for PRESERVE Expansion

Nagre-recruitObservasyonal na pag-aaral

Henry Ford Health, Detroit

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 28, 2025 · NCT07145411

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Detroit

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.